25th Annual Biotech in Europe Forum by Sachs Associates

Returning for its 25th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2025, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.

The main programme for the 25th Annual BEF is spread throughout 2 days (8th - 9th of October) and will feature more than 15 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, including the Rising Stars – Biotech Seed Companies Session, alongside virtual company showcases, which will be available on-demand during the virtual week. We anticipate 650+ delegates will register for the forum from all sectors of Life Sciences, with the target audience being corporate and financial investors/partners, banks, and advisors, with part of the audience participating virtually.

Members of the Swiss Biotech Association benefit from a 15% discount on registration or showcase packages with Online Meeting System Access.